Association between taurine transporter SLC6A6 and breast cancer development and prognosis: a Mendelian randomization analysis
Abstract Background Breast cancer is the most common malignancy among women worldwide, with early screening and diagnosis being crucial for improving patient prognosis. Taurine, as an important metabolite, shows significant changes during breast cancer development, while the taurine transporter SLC6...
Saved in:
| Main Authors: | Xinping Huang, Hailong Shu, Man Xu, Weixiao Ke, Wanting Chen, Wenbin Huang, Hai Wang, Yifan Zhu, Yongxia Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03246-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glutamate transporter SLC1A6 promotes resistance to immunotherapy in cancer
by: Chenchen Li, et al.
Published: (2025-06-01) -
Experimental Substantiation of Taurine Use in Prophylaxis of Isoniazid-Induced Neurotoxic Reactions
by: G. N. Mozhokina, et al.
Published: (2020-05-01) -
Clinical significance and expression of SLC35F6 in bladder urothelial carcinoma
by: Jinling Zhang, et al.
Published: (2024-11-01) -
Whole-exome sequencing and molecular dynamics confirm pathogenicity of a novel SLC6A6 mutation in Leber congenital amaurosis
by: Srikrupa N. Natarajan, et al.
Published: (2025-02-01) -
Investigation of the cytotoxic effects and mechanisms of the SLC39A6-targeting ADC drug BRY812 in CRC
by: Xianglin Liu, et al.
Published: (2025-05-01)